Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade

Journal of Clinical Virology

Volumn 59, Issue 1, 2014, Pages 24-29

  Bryant, Dean ^a   Tristram, Amanda ^a   Liloglou, Triantafillos ^b   Hibbitts, Samantha ^a   Fiander, Alison ^a   Powell, Ned ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cervical cancer; HPV; Human Papillomavirus; Methylation

Indexed keywords

NUCLEOTIDE;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CYTOLOGY; DISEASE SEVERITY; DNA METHYLATION; DYSKARYOSIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REGULATOR GENE; SEPARATION TECHNIQUE; UTERINE CERVIX CANCER; VIRUS GENOME;

AREA UNDER CURVE; AUC; CERVICAL CANCER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CIN; HPV; HUMAN PAPILLOMAVIRUS; LBC; LCR; LIQUID BASED CYTOLOGY; LONG CONTROL REGION; METHYLATION; RECEIVER OPERATING CHARACTERISTIC; ROC;

ADULT; BIOLOGICAL MARKERS; CAPSID PROTEINS; DNA METHYLATION; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84891832246     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.029     Document Type: Article

References (29)

1. Robertson K.D. DNA methylation and human disease. Nature Reviews Genetics 2005, 6:597-610.
2. Hesselink A.T., Heideman D.A., Steenbergen R.D., Coupe V.M., Overmeer R.M., Rijkaart D., et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clinical Cancer Research 2011, 17:2459-2465.
3. Mirabello L., Sun C., Ghosh A., Rodriguez A.C., Schiffman M., Wentzensen N., et al. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. Journal of the National Cancer Institute 2012, 104:556-565.
4. Castle P.E. Gynecological cancer: more evidence supporting human papillomavirus testing. Nature Reviews Clinical Oncology 2012, 9:131-132.
5. Snijders P.J., Verhoef V.M., Arbyn M., Ogilvie G., Minozzi S., Banzi R., et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. International Journal of Cancer 2013, 132:2223-2236.
6. Cuzick J., Bergeron C., von Knebel Doeberitz M., Gravitt P., Jeronimo J., Lorincz A.T., et al. New technologies and procedures for cervical cancer screening. Vaccine 2012, 30(Suppl. 5):F107-F116.
7. Badal V., Chuang L.S., Tan E.H., Badal S., Villa L.L., Wheeler C.M., et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. Journal of Virology 2003, 77:6227-6234.
8. Brandsma J.L., Sun Y., Lizardi P.M., Tuck D.P., Zelterman D., Haines G.K., et al. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009, 389:100-107.
9. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. Journal of Virology 2004, 78:12762-12772.
10. Piyathilake C.J., Macaluso M., Alvarez R.D., Chen M., Badiga S., Edberg J.C., et al. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2011, 117:957-963.
11. Hibbitts S., Jones J., Powell N., Dallimore N., McRea J., Beer H., et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. British Journal of Cancer 2008, 99:1929-1933.
12. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. Journal of Clinical Microbiology 1997, 35:791-795.
13. Powell N.G., Hibbitts S.J., Boyde A.M., Newcombe R.G., Tristram A.J., Fiander A.N. The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population. International Journal of Cancer 2011, 128:1676-1682.
14. Fernandez A.F., Rosales C., Lopez-Nieva P., Grana O., Ballestar E., Ropero S., et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Research 2009, 19:438-451.
15. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Annals of Statistics 2001, 29:1165-1188.
16. Cervical Screening Wales KC53/61/65 statistical report - Adroddiad Ystadegol 2010/2011 data 2011, Cervical Screening Wales, Cardiff, http://www.screeningservices.org.uk/csw/prof/reports/KC53-61-65_10-11.pdf.
17. Mirabello L., Schiffman M., Ghosh A., Rodriguez A.C., Vasiljevic N., Wentzensen N., et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. International Journal of Cancer 2013, 132:1412-1422.
18. Lorincz A.T., Brentnall A.R., Vasiljevic N., Scibior-Bentkowska D., Castanon A., Fiander A., et al. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. International Journal of Cancer 2013, 133:637-644.
19. Bhattacharjee B., Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 2006, 354:280-285.
20. Ding D.C., Chiang M.H., Lai H.C., Hsiung C.A., Hsieh C.Y., Chu T.Y. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. European Journal of Obstetrics and Gynecology and Reproductive Biology 2009, 147:215-220.
21. Hong D., Ye F., Lu W., Hu Y., Wan X., Chen Y., et al. Methylation status of the long control region of HPV 16 in clinical cervical specimens. Molecular Medicine Reports 2008, 1:555-560.
22. Badal V., Chuang L.S.H., Tan E.H-H., Badal S., Villa L.L., Wheeler C.M., et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. Journal of Virology 2003, 77:6227-6234.
23. Hublarova P., Hrstka R., Rotterova P., Rotter L., Coupkova M., Badal V., et al. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. International Journal of Gynecological Cancer 2009, 19:321-325.
24. Patel D.A., Rozek L.S., Colacino J.A., Van Zomeren-Dohm A., Ruffin M.T., Unger E.R., et al. Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. Journal of Virological Methods 2012.
25. Lechner M., Fenton T., West J., Wilson G., Feber A., Henderson S., et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Medicine 2013, 5:15.
26. Burgers W.A., Blanchon L., Pradhan S., de Launoit Y., Kouzarides T., Fuks F. Viral oncoproteins target the DNA methyltransferases. Oncogene 2007, 26:1650-1655.
27. Kalantari M., Chase D.M., Tewari K.S., Bernard H.U. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. Journal of Medical Virology 2010, 82:311-320.
28. Turan T., Kalantari M., Cuschieri K., Cubie H.A., Skomedal H., Bernard H.U. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 2007, 361:185-193.
29. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clinical Science 2006, 110:525-541.